Open Access

The COMPASS study... Vascular protection with rivaroxaban in patients with CAD or PAD.

logo

Congress Presentation

About the speakers

Doctor Stuart J Connolly

McMaster University, Hamilton (Canada)
10 presentations
0 follower

Doctor John William Eikelboom

McMaster University, Hamilton (Canada)
34 presentations
0 follower

3 more presentations in this session

Opening remarks - Exploring vascular protection in patients with CAD or PAD through the potential of factor Xa inhibition... The COMPASS study.

Speaker: Doctor S. Yusuf (Hamilton, CA)

Thumbnail

Which patients with CAD or PAD are at the highest risk of cardiovascular events... What do the registries teach us.

Speaker: Professor P. Steg (Paris, FR) Professor D. Bhatt (Boston, US)

Thumbnail

Closing remarks - Exploring vascular protection in patients with CAD or PAD through the potential of factor Xa inhibition... The COMPASS study.

Speaker: Doctor S. Connolly (Hamilton, CA)

Thumbnail

Access the full session

Exploring vascular protection in patients with coronary artery disease (CAD) or peripheral artery disease (PAD) through the potential of factor Xa inhibition... The COMPASS study

Speakers: Doctor S. Connolly, Doctor J. Eikelboom, Doctor S. Yusuf, Professor P. Steg, Professor D. Bhatt...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk